CNS Pharmaceuticals Inc
NASDAQ:CNSP
CNS Pharmaceuticals Inc
NASDAQ:CNSP
Price:
3.04
USD
-2.88%
Market Closed
Market Cap:
$1.9m
Balance Sheet
Balance Sheet Decomposition
CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc
Balance Sheet
CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
7
|
14
|
5
|
10
|
1
|
6
|
|
| Cash Equivalents |
0
|
0
|
7
|
14
|
5
|
10
|
1
|
6
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
2
|
3
|
1
|
1
|
|
| Total Current Assets |
0
|
1
|
8
|
16
|
7
|
13
|
2
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+325%
|
8
+1 063%
|
16
+100%
|
9
-45%
|
13
+49%
|
2
-87%
|
9
+412%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
2
|
4
|
6
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
0
|
2
|
3
|
5
|
6
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+459%
|
0
-75%
|
2
+516%
|
3
+36%
|
5
+90%
|
6
+25%
|
3
-59%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
8
|
11
|
21
|
35
|
51
|
70
|
84
|
|
| Additional Paid In Capital |
0
|
7
|
19
|
35
|
42
|
59
|
65
|
91
|
|
| Total Equity |
0
N/A
|
1
-817%
|
8
N/A
|
14
+84%
|
6
-56%
|
8
+32%
|
4
N/A
|
6
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+325%
|
8
+1 063%
|
16
+100%
|
9
-45%
|
13
+49%
|
2
-87%
|
9
+412%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
